Hello, Welcome to Shine Consultant !
Summit & Event Advisor & Insight Research & Analysis
Guest Information
Bin Li
Bin Li



 Ally Bridge LB Healthcare Fund


Dr. Bin Li is the founder and CIO of ABG-LB Healthcare Fund and a partner of Ally Bridge Group, a global healthcare investment fund based in Hong Kong. Previously, he was a Managing Director and the Head of Greater China Healthcare Research at Morgan Stanley and led the coverage of Greater China healthcare industry. Since he moved to Morgan Stanley and established the healthcare research practice in Hong Kong in 2008, he had been ranked as the top analyst in China healthcare industry by the most widely recognized investor surveys. He was ranked No. 1 Asia Healthcare Analyst by the Institutional Investor (II) for seven consecutive years (2008-2014) and No.1 China Healthcare Analyst each year by II since the poll started in 2010 (2010-2014). He was also repeatedly ranked as No. 1 Asia Healthcare Analyst by all other independent investor surveys including Greenwich and Asiamoney. In addition, he was rated as No. 1 in Wall Street Journal's Best Asia Healthcare Analysts poll for his stock selection in 2010.

Before joining Morgan Stanley, he was a senior healthcare research analyst at Merrill Lynch (Hong Kong) and responsible for the firm’s stock research efforts on Asia healthcare. Before moving to Hong Kong in 2007, he was a key member of a top-rank US pharmaceutical research team at Merrill Lynch based in New York.

Dr. Li has over 20-year experience in healthcare industry. He received his Ph.D. in biochemistry and MBA from New York University and bachelor degree from Fudan University, China. Prior to his sell-side career, he worked at Merck Research Laboratory as a scientist and published papers on peer-reviewed science journals.